 Maryann Degroote
Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antitubercular Agents | 7 | 2014 | 206 | 0.750 |
Why?
| | Capreomycin | 1 | 2011 | 2 | 0.380 |
Why?
| | Mycobacterium | 3 | 2018 | 108 | 0.280 |
Why?
| | Models, Biological | 1 | 2011 | 1783 | 0.220 |
Why?
| | Tuberculosis | 3 | 2012 | 279 | 0.200 |
Why?
| | Mycobacterium tuberculosis | 5 | 2014 | 314 | 0.200 |
Why?
| | Tuberculosis, Pulmonary | 2 | 2014 | 141 | 0.190 |
Why?
| | Mycobacterium Infections | 3 | 2017 | 63 | 0.180 |
Why?
| | Benzothiazoles | 1 | 2018 | 33 | 0.150 |
Why?
| | Drug Discovery | 1 | 2018 | 142 | 0.140 |
Why?
| | Respiratory System | 1 | 2017 | 157 | 0.120 |
Why?
| | Anti-Bacterial Agents | 3 | 2018 | 1809 | 0.120 |
Why?
| | Isoniazid | 2 | 2012 | 63 | 0.110 |
Why?
| | Tuberculosis, Multidrug-Resistant | 2 | 2012 | 58 | 0.110 |
Why?
| | Phylogeny | 2 | 2017 | 904 | 0.110 |
Why?
| | Drug Evaluation, Preclinical | 2 | 2012 | 184 | 0.110 |
Why?
| | Mice | 8 | 2018 | 17787 | 0.090 |
Why?
| | Monte Carlo Method | 1 | 2011 | 148 | 0.090 |
Why?
| | Torticollis | 1 | 2011 | 12 | 0.090 |
Why?
| | Tissue Distribution | 1 | 2011 | 332 | 0.090 |
Why?
| | Azithromycin | 1 | 2011 | 100 | 0.090 |
Why?
| | Biological Transport | 1 | 2011 | 418 | 0.080 |
Why?
| | Macrolides | 2 | 2011 | 65 | 0.080 |
Why?
| | Bayes Theorem | 1 | 2011 | 405 | 0.080 |
Why?
| | Cystic Fibrosis | 2 | 2011 | 1114 | 0.070 |
Why?
| | Autophagy | 1 | 2011 | 284 | 0.070 |
Why?
| | Otitis Media | 1 | 2011 | 165 | 0.070 |
Why?
| | Metabolomics | 1 | 2014 | 678 | 0.070 |
Why?
| | Computer Simulation | 1 | 2011 | 978 | 0.070 |
Why?
| | Bacterial Proteins | 1 | 2012 | 879 | 0.060 |
Why?
| | Disease Models, Animal | 3 | 2012 | 4295 | 0.060 |
Why?
| | Molecular Epidemiology | 1 | 2005 | 68 | 0.060 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2005 | 78 | 0.060 |
Why?
| | Animals | 9 | 2018 | 36940 | 0.060 |
Why?
| | Mycobacterium avium-intracellulare Infection | 1 | 2005 | 62 | 0.060 |
Why?
| | Mice, Inbred C57BL | 2 | 2011 | 5757 | 0.050 |
Why?
| | Kidney | 1 | 2011 | 1468 | 0.050 |
Why?
| | Biomarkers | 1 | 2014 | 4149 | 0.050 |
Why?
| | Lung | 2 | 2012 | 4060 | 0.040 |
Why?
| | Drug Design | 2 | 2012 | 167 | 0.040 |
Why?
| | Mice, Inbred BALB C | 2 | 2012 | 1272 | 0.040 |
Why?
| | Amides | 1 | 2018 | 93 | 0.040 |
Why?
| | Mycolic Acids | 1 | 2017 | 7 | 0.030 |
Why?
| | Base Composition | 1 | 2017 | 78 | 0.030 |
Why?
| | Oregon | 1 | 2017 | 74 | 0.030 |
Why?
| | Salmonella typhimurium | 1 | 1999 | 183 | 0.030 |
Why?
| | Bacterial Typing Techniques | 1 | 2017 | 44 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2018 | 570 | 0.030 |
Why?
| | Genes, Bacterial | 1 | 2017 | 164 | 0.030 |
Why?
| | Species Specificity | 1 | 2018 | 585 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2018 | 361 | 0.030 |
Why?
| | Superoxide Dismutase | 1 | 1999 | 346 | 0.030 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 1999 | 328 | 0.030 |
Why?
| | DNA, Bacterial | 1 | 2017 | 337 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2005 | 2691 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2017 | 549 | 0.030 |
Why?
| | Female | 6 | 2014 | 73304 | 0.030 |
Why?
| | Humans | 9 | 2017 | 137585 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2017 | 812 | 0.030 |
Why?
| | Phagosomes | 1 | 2011 | 44 | 0.020 |
Why?
| | Pyrazinamide | 1 | 2011 | 12 | 0.020 |
Why?
| | Aza Compounds | 1 | 2011 | 14 | 0.020 |
Why?
| | COS Cells | 1 | 2011 | 188 | 0.020 |
Why?
| | Fluoroquinolones | 1 | 2011 | 51 | 0.020 |
Why?
| | Autopsy | 1 | 2011 | 95 | 0.020 |
Why?
| | Lysosomes | 1 | 2011 | 141 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2011 | 206 | 0.020 |
Why?
| | Ear, Middle | 1 | 2011 | 85 | 0.020 |
Why?
| | HIV Infections | 1 | 2005 | 2836 | 0.020 |
Why?
| | Rifampin | 1 | 2011 | 84 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2012 | 688 | 0.020 |
Why?
| | Drug Resistance, Bacterial | 1 | 2011 | 186 | 0.020 |
Why?
| | Microtubule-Associated Proteins | 1 | 2011 | 196 | 0.020 |
Why?
| | Quinolines | 1 | 2011 | 178 | 0.020 |
Why?
| | HeLa Cells | 1 | 2011 | 636 | 0.020 |
Why?
| | Sirolimus | 1 | 2011 | 276 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2011 | 665 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2011 | 1066 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2011 | 840 | 0.020 |
Why?
| | Guinea Pigs | 1 | 2008 | 158 | 0.020 |
Why?
| | Adult | 4 | 2014 | 37929 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2014 | 10811 | 0.010 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2005 | 67 | 0.010 |
Why?
| | Mycobacterium avium Complex | 1 | 2005 | 88 | 0.010 |
Why?
| | Age Distribution | 1 | 2005 | 392 | 0.010 |
Why?
| | Sex Distribution | 1 | 2005 | 375 | 0.010 |
Why?
| | Reference Values | 1 | 2005 | 816 | 0.010 |
Why?
| | Macrophages | 1 | 2011 | 1547 | 0.010 |
Why?
| | Prospective Studies | 1 | 2014 | 7604 | 0.010 |
Why?
| | Genotype | 1 | 2005 | 1916 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2005 | 2031 | 0.010 |
Why?
| | Rats | 1 | 2008 | 5647 | 0.010 |
Why?
| | Incidence | 1 | 2005 | 2804 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1999 | 343 | 0.010 |
Why?
| | Isoenzymes | 1 | 1999 | 304 | 0.010 |
Why?
| | Virulence | 1 | 1999 | 267 | 0.010 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 1999 | 283 | 0.010 |
Why?
| | Disease Progression | 1 | 2005 | 2757 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2005 | 3556 | 0.010 |
Why?
| | Male | 3 | 2014 | 67762 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2005 | 15657 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2828 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2005 | 5131 | 0.010 |
Why?
| | Risk Assessment | 1 | 2005 | 3457 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1999 | 2139 | 0.010 |
Why?
| | Cohort Studies | 1 | 2005 | 5742 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1999 | 2900 | 0.010 |
Why?
| | Middle Aged | 2 | 2005 | 33479 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2005 | 7635 | 0.010 |
Why?
| | Mutation | 1 | 1999 | 3958 | 0.000 |
Why?
| | Aged | 1 | 2005 | 23961 | 0.000 |
Why?
|
|
Degroote's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|